<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01770340</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-NR:2010-0004/0</org_study_id>
    <nct_id>NCT01770340</nct_id>
  </id_info>
  <brief_title>Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial</brief_title>
  <official_title>Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Earlier studies were able to show that an improvement of the erectile function following a
      non-nerve sparing radical prostatectomy could be achieved using an autologous nerve graft.

      The investigators evaluate the use of the implantation of the allogenic nerve graft Avance®
      in patients undergoing non nerve-sparing radical prostatectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective randomised and single-blind, clinical phase-IV study, 60 patients are
      randomized into the treatment group and the control group. The follow-up is at least 24
      months.

      The inclusion criteria were localized prostate cancers cT3 and/or Gleason score ≥ 7 (a or b)
      and/or prostate-specific antigen (PSA) ≥ 20 ng/ml and furthermore an erectile function with
      an IIEF ≥ 21 (IIEF-6).

      The operation carried out is a standardised, robot assisted laparoscopic radical
      prostatectomy with total excision of both neurovascular bundles.

      The Outcome measurement is done with the &quot;quality of life questionnaire before and after
      prostate surgery&quot; that includes the &quot;International Index of Erectile Function&quot; (IIEF)
      questionnaire.

      The limitations are a small cohort, a short observation period and the lack of statistical
      analysis due to a still low number of patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy</measure>
    <time_frame>24 months</time_frame>
    <description>Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy. To show a complete impotence in the control group and an enhancement of the initial postoperative impotence in the treatment group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>24 months</time_frame>
    <description>Monitoring of side effects and complications in connection with the nerve-implantation.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Documented will be the extra time required for the nerve implantation</measure>
    <time_frame>at the time of operation</time_frame>
    <description>How much operation-time takes the nerve implantation? The time is stopped which is required for the implantation of the nerve. Start is when the prostate was removed and was deposited in the extraction bag. Stop when the anastomosis of the nerves is stitched and the anastomosis of the urethra begins.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Erectile Dysfunction Following Radical Prostatectomy</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Radical prostatectomy without implantation of allograft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radical prostatectomy with implantation of allograft</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Radical prostatectomy with implantation of allograft</intervention_name>
    <description>Interposition of resected neurovascular bundles with allograft Avance®</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical prostatectomy without implantation of allograft</intervention_name>
    <description>No interposition of resected neurvascular bundles</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Localized intermediate-risk or high-risk prostate cancer cT3

          -  Gleason score ≥ 7 (3+4 and/or 4+3) and/or

          -  PSA ≥ 20 ng/ml

          -  intact preoperative erectile function with an IIEF ≥ 21 (IIEF-6).

        Exclusion Criteria:

          -  IIEF &lt; 21

          -  Operations in the past 6 months which could limit the erectile function

          -  Erectile dysfunction in the history or current medication for erectile dysfunction

          -  Current involvement in another comparable study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hubert John, Chefarzt</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beat Foerster, MD</last_name>
    <email>beat.foerster@ksw.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <state>Kanton Zürich</state>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hubert John, Chefarzt</last_name>
      <phone>+41 52 266 2982</phone>
      <email>hubert.john@ksw.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2012</study_first_submitted>
  <study_first_submitted_qc>January 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2013</study_first_posted>
  <last_update_submitted>November 9, 2015</last_update_submitted>
  <last_update_submitted_qc>November 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>radical prostatectomy</keyword>
  <keyword>erectile function</keyword>
  <keyword>nerve grafting</keyword>
  <keyword>allogenic</keyword>
  <keyword>prostate cancer</keyword>
  <keyword>Allogenic nerve graft</keyword>
  <keyword>Time required for nerve grafting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

